Ashland, MA, United States of America

Pearl Bakhru

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Pearl Bakhru

Introduction

Pearl Bakhru is an accomplished inventor based in Ashland, MA (US). He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents to his name, Bakhru is recognized for his work in developing novel therapeutic approaches to combat tumor evasion.

Latest Patents

Bakhru's latest patents focus on multispecific binding constructs against checkpoint molecules. These inventions aim to inhibit tumor evasion by reducing immune checkpoint suppression. The disclosed compositions block the interaction between PD-1 and its ligand, promoting the interaction of the cells on which PD-1 and its ligand are expressed. Additionally, methods for using these compositions are provided, showcasing the potential for significant advancements in cancer treatment.

Career Highlights

Pearl Bakhru is currently associated with Compass Therapeutics LLC, where he continues to push the boundaries of cancer research. His work is pivotal in developing therapies that enhance the immune system's ability to fight tumors. Bakhru's innovative spirit and dedication to research have positioned him as a key figure in the field.

Collaborations

Bakhru collaborates with talented individuals such as Bing Gong and Rachel Rennard, who contribute to the dynamic research environment at Compass Therapeutics LLC. Their combined expertise fosters a culture of innovation and progress in the development of new therapeutic strategies.

Conclusion

Pearl Bakhru's contributions to immunology through his patents and collaborations highlight his commitment to advancing cancer treatment. His innovative work continues to inspire and pave the way for future breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…